Table 4 Inflammatory mediators and quality of life.

From: Systemic inflammation contributes to impairment of quality of life in chronic pancreatitis

Predictive Variable

Questionnaire

Quality of Life Domain(s)

Mean Score (Low)

Mean Score (High)

Bonferroni p-value

Eotaxin

PAN-28

Bowel Function

24.5

34.9

0.03

Abdominal Bloating

54.6

37.6

0.009

IL-7

QLQ-C30

Global Quality of Life

55.8

48.2

0.04

Fatigue

43.5

53.1

0.03

Nausea and Vomiting

20.0

29.8

0.03

Dyspnoea

19.3

30.4

0.01

Diarrhoea

17.2

27.4

0.01

IL-8

QLQ-C30

Global Quality of Life

56.0

48.3

0.04

Physical Functioning

78.9

67.8

0.002

Cognitive Functioning

77.5

68.3

0.02

Nausea and Vomiting

20.0

29.4

0.04

Dyspnoea

20.1

29.1

0.05

Appetite Loss

32.6

44.0

0.03

IL-12/IL-23p40

QLQ-C30

Dyspnoea

29.6

29.5

0.03

IL-16

QLQ-C30

Global Quality of Life

56.7

47.5

0.01

Physical Functioning

78.4

68.2

0.005

Cognitive Functioning

77.5

68.1

0.02

Fatigue

43.0

53.3

0.02

Nausea and Vomiting

17.2

32.3

0.001

Dyspnoea

19.2

30.1

0.02

IP-10

QLQ-C30

Dyspnoea

20.2

29.3

0.04

PAN-28

Bowel Function

19.7

38.3

<0.0001

MCP-4

PAN-28

Bowel Function

23.8

34.8

0.02

MDC

QLQ-C30

Physical Functioning

78.7

67.8

0.003

Fatigue

43.1

53.3

0.02

Nausea and Vomiting

17.2

32.4

0.001

Dyspnoea

17.9

31.5

0.002

Bowel Function

22.0

36.1

0.002

Weight Loss

24.2

39.9

0.02

MIP-1a

QLQ-C30

Global Quality of Life

56.5

47.6

0.02

Physical Functioning

80.2

66.2

<0.0001

Cognitive Functioning

78.3

67.2

0.004

Fatigue

40.9

55.6

0.001

Nausea and Vomiting

17.6

32.1

0.001

Dyspnoea

18.6

30.8

0.007